The Retention Revolution: Travel is the primary reason for a 30% patient dropout rate. Moving the clinical site to the home removes this barrier, which is especially important for reaching participants across the diverse islands of the Philippines.
Philippine FDA Readiness: The Philippine Food and Drug Administration (FDA) aligns with global standards, requiring a Quality by Design approach for trials, in line with updated ICH E6(R3) guidelines.
Unbroken Chain of Custody: Keeping unapproved medicines stable outside a clinic needs IoT sensors and white-glove delivery, which is critical in the Philippines' tropical climate.
Scalable Compliance: Success in the Philippines means expertly managing the FDA's import permit process for investigational products and navigating complex inter-island logistics.
Traditional site-centric models of research are hitting a wall in 2026. Recruitment goals are often missed because patients cannot manage the time and travel for hospital visits, a significant challenge in an archipelago like the Philippines. We've built the DHL Health Logistics network to solve this challenge directly. Our 2-billion-euro investment ensures you have the GDP-certified infrastructure and specialised handling needed to reach patients anywhere, from Luzon to Mindanao. Direct-to-Patient (DtP) clinical trials move the laboratory to the living room while keeping the highest levels of safety.
Travel is the main reason participants leave clinical studies. When you move the trial site to the patient, you reduce missed visits and screen failures.
Travel Distance: Cancer trial patients travel a median of nearly 42 miles for Phase I studies.
Archipelagic Hurdles: In the Philippines, the logistical challenge is not just distance but also the complexity of inter-island travel, which can make trial participation impossible for many.
Human Connection: Technical couriers act as a professional extension of the clinical site at the doorstep.
Supportive Experience: White-glove services go beyond simple delivery to build participant trust and confidence.
DHL Health Logistics provides the professional bridge between your lab and the participant. We understand that a courier is often the only face of the trial that a patient sees.
The Philippine FDA is harmonising its rules to support decentralised models, aligning with global best practices. The new ICH E6(R3) guidelines require you to prove the drug stayed stable from the depot to the patient’s refrigerator.
Global Standards: The Philippine FDA requires all clinical trials to follow the latest International Council of Harmonisation (ICH) Good Clinical Practice (GCP) guidelines. This ensures data integrity and participant safety, no matter where they are located.
Strict Accountability: To import investigational products, you need an Import License from the FDA, which is tied to your approved clinical trial protocol. This ensures every shipment is accounted for.
Thermal Protection: Advanced shippers maintain 2 to 8°C or -20°C for up to 120 hours, a vital capability in the warm climate of the Philippines.
Digital Proof: IoT sensors transmit live data to show exactly when a participant received the shipment, creating a verifiable audit trail for regulators.
Our investment in digital tools ensures you have a full thermal audit trail. This transparency is a requirement for satisfying quality assurance teams in 2026.
Delivering unapproved medicines to a private address is strictly regulated in the Philippines. You need a partner who understands the local regulatory landscape, including the requirements of the FDA, Bureau of Customs, and even the Bureau of Internal Revenue (BIR).
FDA Oversight: All clinical trials and the importation of the products used in them must be approved by the Philippine FDA. This involves securing a License to Operate (LTO) as a sponsor or CRO and a specific Import License for the investigational products.
Customs & Tax Compliance: Beyond the FDA, importers must be accredited with the Bureau of Customs (BOC) and the BIR. For certain products, pre-payment of taxes may be required before customs release, so having a partner who can manage this process is key to avoiding delays.
Expert Navigation: Our local specialists work with authorities like the FDA and BOC to keep your trial on track. We help manage the complex documentation needed for customs clearance at hubs like Ninoy Aquino Airport.
Expanded Footprint: Proper licensing allows you to reach regions across the Philippines' 7,000 islands that were previously considered too complex for clinical trials.
Security and privacy are vital when delivering sensitive products to a home. You must ensure the medicine is handed directly to the verified participant or their legal representative.
Identity Verification: We check IDs against trial records before any package is handed over.
Point-of-Use Delivery: Couriers place the medication directly into the participant’s storage or refrigerator.
Instruction Support: We confirm the patient knows how to handle the packaging.
Safe Disposal: We collect used kits or sharp containers for medical-grade destruction.
A DtP trial does not end at the doorstep. You must also manage the flow of biological samples and unused drugs back to the central lab.
Stability Windows: Blood or urine samples must be collected and returned within strict time limits.
Data Integrity: If a sample gets warm during transit, especially during inter-island transport in the Philippines, the trial data is ruined.
Remote Reach: We use specialised transport to reach participants in remote provinces and islands, overcoming local infrastructure challenges.
Unified Visibility: A clinical research associate in Manila should see the same data as a sponsor in London.
Direct-to-Patient logistics is no longer just a future concept. It’s the best way to improve the patient experience and protect your data. DHL Health Logistics is ready to help you scale your research across the Philippines. Open a DHL Business Account today and connect with a DHL specialist to review your trial plan and reach your participants with confidence.
They remove the physical burden of travel by delivering medicine to the participant's home. This makes it easier for patients to stay in the study while keeping their daily routines, a major advantage for participants living in different parts of the Philippine archipelago.
These 2026 guidelines require sponsors to use a Quality by Design approach. The Philippine FDA requires adherence to these international standards, meaning you must have digital proof that your investigational products stayed stable throughout the entire journey to the patient.
We use real-time IoT sensors that transmit live location and thermal data to a dashboard. This ensures you receive an immediate alert if the shipment deviates from its required range, which is especially important given the climate challenges in the Philippines.
Yes, but you need a partner that handles the local medical licenses in each country. Using a standardised digital platform ensures your data remains comparable across markets like the Philippines and its neighbours.
Yes, our couriers perform a verified delivery protocol. This includes checking the participant's ID to ensure the sensitive medication is handed to the correct person.
Share
